[HTML][HTML] Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
L Anabel Sinberger, T Zahavi, A Sonnenblick… - Scientific Reports, 2023 - nature.com
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
LA Sinberger, T Zahavi, A Sonnenblick… - Scientific …, 2023 - pubmed.ncbi.nlm.nih.gov
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
[HTML][HTML] Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
LA Sinberger, T Zahavi, A Sonnenblick… - Scientific …, 2023 - ncbi.nlm.nih.gov
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer
L Anabel Sinberger, T Zahavi… - Scientific …, 2023 - ui.adsabs.harvard.edu
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.
T Zahavi, A Sonnenblick, M Salmon-Divon - Scientific Reports, 2023 - europepmc.org
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
Coexistent ARID1A-PIK3CA mutations are associated with immune-related pathways in luminal breast cancer.
T Zahavi, A Sonnenblick, M Salmon-Divon - Scientific Reports, 2023 - europepmc.org
Up to 40% of luminal breast cancer patients carry activating mutations in the PIK3CA gene.
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …
PIK3CA mutations commonly co-occur with other mutations, but the implication of this co …